InMed Announces Appointment of Chief Operating Officer
VANCOUVER, British Columbia, July 18, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader...
VANCOUVER, British Columbia, July 18, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader...
TORONTO, July 18, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) is pleased to announce a...
- Positive 12-Month Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet...
Progress continues apace with multiple trials expected to enter clinic later this year First US patent granted LONDON, July 15,...
VANCOUVER, British Columbia, July 15, 2022 (GLOBE NEWSWIRE) -- Agra Ventures Ltd. (“AGRA” or the “Company”) (CSE: AGRA) (OTC: AGFAF)...
TORONTO, ONTARIO, July 15, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a...
NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company...
SOUTH SAN FRANCISCO, Calif., July 15, 2022 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused...
OTTAWA, July 15, 2022 (GLOBE NEWSWIRE) -- Today’s ruling from the BC Court of Appeal in the Cambie Surgeries Corporation...
Bavarian Nordic to supply an additional 2.5 million doses of JYNNEOS® vaccine, bringing deliveries in 2022 and 2023 to a...
BOSTON, July 15, 2022 (GLOBE NEWSWIRE) -- This week, with support from community partners at Aletheia House, Bicycle Health flew...
MARKHAM, Ontario, July 15, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced...
PRESS RELEASE 15 July 2022 The English text is an unofficial translation. In case of any discrepancies between the Swedish...
IRVINE, Calif., July 15, 2022 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced an update to its shareholders...
Latest clinical data underscores the value and impact of whole person care Member Satisfaction Members who use multiple chronic condition...
- Study participants had an 81%-98% reduction in annualized anti-VEGF injections and demonstrated continuous aflibercept expression levels through three years...
Endo affiliate, Paladin Labs, will commercialize Quoin’s lead asset for Netherton Syndrome in CanadaASHBURN, Va., July 15, 2022 (GLOBE NEWSWIRE)...
On Track for FY 2022 Guidance Q1 2022 revenue rises 3% to €10.3 million Completed phase out of COVID-19 Business...
Interviews with global CAEs show organizations driving change in the internal audit function and looking to attract and retain top...
The Business Research Company's healthcare BPO market research report expands on key drivers, trends, and growth opportunities in the market....